AGY fundamentals
Key facts
Market capitalization309.82 MGBP
Basic EPS (TTM)−0.01GBP
Founded2004
CEOManuel Llobet
Websiteallergytherapeutics.com
About
Allergy Therapeutics Plc is a biotechnology company, which engages in the Research and Development of allergy treatments. The company was founded by Keith Iain Carter in 1998 and is headquartered in Worthing, the United Kingdom.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
−180%
−140%
−100%
−60%
−20%
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
−40.00 M
−20.00 M
0.00
20.00 M
40.00 M
Revenue
Net income
Net margin %
Revenue breakdown
Revenue streams and regions a business earns money from
Estimates
Revenue and Earnings forecasts and estimates accuracy
Dividends
Dividend yield, history and sustainability
AGY does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company